Pharma-Bio Serv (OTCMKTS:PBSV) Issues Earnings Results

Pharma-Bio Serv (OTCMKTS:PBSV) announced its earnings results on Monday. The company reported ($0.01) EPS for the quarter, missing the consensus estimate of $0.03 by ($0.04), Yahoo Finance reports. The company had revenue of $2.42 million for the quarter, compared to the consensus estimate of $3.50 million. Pharma-Bio Serv had a negative return on equity of 0.04% and a negative net margin of 0.05%.

Pharma-Bio Serv Stock Performance

PBSV stock opened at $0.63 on Wednesday. The business’s fifty day moving average price is $0.62 and its two-hundred day moving average price is $0.69. Pharma-Bio Serv has a fifty-two week low of $0.52 and a fifty-two week high of $1.09.

About Pharma-Bio Serv

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.